Another study by Cabaro et al. [24], which analysed cytokine profiles of COVID‐19 patients, revealed that infection with SARS‐CoV‐2 activates Type 1, Type 2 and Type 3 immunity, resulting in increased concentration levels of proinflammatory cytokines such as IL‐6. This evidence concerns the gene IL6 and COVID-19.